Skip to content

Fospropofol

Lusedra (fospropofol) is a small molecule pharmaceutical. Fospropofol was first approved as Lusedra on 2008-12-12. Lusedra's patent is valid until 2022-07-01 (FDA).
Trade Name Lusedra
Common Name Fospropofol
Indication
Drug Class Phosphoro-derivatives
Fospropofol
Get full access now